MBIO:NASDAQ
Mustang Bio Inc
$0.37
arrow_downward
-0.90%(-0.0034) 1D
Oct 19, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBIO...
Open
$0.37
High
$0.38
Low
$0.37
Mkt. cap
2.80M
Avg. vol.
38.60K
Volume
9.12K
52-wk high
$1.69
52-wk low
$0.37
EPS
-$0.46
Beta
2.09
Shares outstanding
6.73M
No. of employees
4
Open
$0.37
High
$0.38
Low
$0.37
Mkt. cap
2.80M
Avg. vol.
38.60K
Volume
9.12K
52-wk high
$1.69
52-wk low
$0.37
EPS
-$0.46
Beta
2.09
Shares outstanding
6.73M
No. of employees
4
News stories
From web sources and news partners
BigGo Finance
·
16 minutes ago
Dow Falls 36 Points for Second Straight Session as Oil Rally Weighs, AI-Related Buying Provides Support
Bloomberg
·
1 hour ago
US Stock Futures Edge Higher After Chipmaker Rally: Markets Wrap
TradingView
·
1 hour ago
Nasdaq Jumps Past 1 Percent as VIX Swings While Dow Dips Below Its 50-Day Line
Investing.com
·
2 hours ago
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.07%
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees4
Founded2015
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitemustangbio.com